Anebulo Pharmaceuticals's other current assets is $230K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Anebulo Pharmaceuticals (ANEB) currently reports a other current assets of $230K as of December 2025. That compares with $400K in the prior-year period — down 41.5% year over year. Use the charts on this page to explore Anebulo Pharmaceuticals's other current assets history and peer comparisons.
Anebulo Pharmaceuticals's other current assets decreased from $400K to $230K — a 41.5% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Anebulo Pharmaceuticals reported $230K in other current assets as of December 2025. That compares with $400K in the prior-year period — down 41.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current assets of $230K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anebulo Pharmaceuticals, and consider following ANEB for alerts when major investors trade the stock.
Anebulo Pharmaceuticals is classified in the Healthcare sector. On other current assets, it currently shows $230K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ANEB with unrelated industries.